Simplex Trading
AGIO icon

Simplex Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Simplex Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
6,400
-12,400
-66% -$352K ﹤0.01% 4215
2025
Q4 		$512K Sell
18,800
-24,300
-56% -$853K ﹤0.01% 3286
2025
Q3 		$1.73M Buy
43,100
+24,100
+127% +$906K ﹤0.01% 2470
2025
Q2 		$631K Sell
19,000
-800
-4% -$24.2K ﹤0.01% 3258
2025
Q1 		$580K Buy
19,800
+19,100
+2,729% +$634K ﹤0.01% 3239
2024
Q4 		$23K Sell
700
-12,100
-95% -$568K ﹤0.01% 6556
2024
Q3 		$568K Sell
12,800
-7,100
-36% -$322K ﹤0.01% 3460
2024
Q2 		$858K Sell
19,900
-13,400
-40% -$484K ﹤0.01% 3078
2024
Q1 		$973K Buy
33,300
+20,000
+150% +$536K ﹤0.01% 3150
2023
Q4 		$296K Buy
13,300
+9,500
+250% +$213K ﹤0.01% 4241
2023
Q3 		$94K Buy
3,800
+2,300
+153% +$60.8K ﹤0.01% 5149
2023
Q2 		$42K Buy
1,500
+200
+15% +$4.98K ﹤0.01% 6001
2023
Q1 		$29K Sell
1,300
-65,300
-98% -$1.73M ﹤0.01% 6508
2022
Q4 		$1.87M Buy
66,600
+51,200
+332% +$1.44M ﹤0.01% 1927
2022
Q3 		$435K Sell
15,400
-3,500
-19% -$93.9K ﹤0.01% 3626
2022
Q2 		$419K Buy
18,900
+7,100
+60% +$160K ﹤0.01% 3665
2022
Q1 		$343K Buy
11,800
+11,700
+11,700% +$357K ﹤0.01% 4351
2021
Q4 		$3K Sell
100
-13,900
-99% -$559K ﹤0.01% 9785
2021
Q3 		$789K Buy
14,000
+100
+0.7% +$4.83K ﹤0.01% 3434
2021
Q2 		$766K Buy
13,900
+13,711
+7,254% +$767K ﹤0.01% 3523
2021
Q1 		$975K Buy
189
+6
+3% +$297 ﹤0.01% 2425
2020
Q4 		$792K Buy
183
+160
+696% +$6.33K ﹤0.01% 2849
2020
Q3 		$80K Sell
23
-140
-86% -$6.14K ﹤0.01% 5131
2020
Q2 		$871K Sell
163
-268
-62% -$12.4K ﹤0.01% 2275
2020
Q1 		$1.53M Sell
431
-137
-24% -$6.33K ﹤0.01% 1508
2019
Q4 		$2.71M Buy
568
+513
+933% +$19.4K 0.01% 1227
2019
Q3 		$178K Sell
55
-77
-58% -$3.19K ﹤0.01% 3683
2019
Q2 		$658K Sell
132
-86
-39% -$4.6K ﹤0.01% 2317
2019
Q1 		$1.47M Sell
218
-113
-34% -$6.58K ﹤0.01% 1644
2018
Q4 		$1.53M Buy
331
+163
+97% +$10.1K ﹤0.01% 1283
2018
Q3 		$1.29M Sell
168
-33
-16% -$2.65K ﹤0.01% 1625
2018
Q2 		$1.69M Buy
201
+17
+9% +$1.48K 0.01% 1282
2018
Q1 		$120K Buy
184
+132
+254% +$10.2K 0.01% 1652
2017
Q4 		$12K Buy
+52
New +$3.27K ﹤0.01% 3717
2017
Q3 		– Sell
-33
Closed -$6K – 5804
2017
Q2 		$6K Sell
33
-107
-76% -$5.47K ﹤0.01% 4391
2017
Q1 		$97K Buy
140
+101
+259% +$4.84K ﹤0.01% 1777
2016
Q4 		$9K Buy
39
+5
+15% +$262 ﹤0.01% 3808
2016
Q3 		$12K Buy
34
+11
+48% +$479 ﹤0.01% 3436
2016
Q2 		$3K Buy
23
+7
+44% +$346 ﹤0.01% 4579
2016
Q1 		$2K Buy
16
+13
+433% +$556 ﹤0.01% 4646
2015
Q4 		$1K Sell
3
-86
-97% -$5.64K ﹤0.01% 4755
2015
Q3 		$10K Buy
89
+27
+44% +$2.64K ﹤0.01% 3409
2015
Q2 		$48K Buy
62
+8
+15% +$862 ﹤0.01% 1721
2015
Q1 		$38K Sell
54
-114
-68% -$12.8K ﹤0.01% 1764
2014
Q4 		$284K Buy
+168
New +$15K 0.03% 447

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Simplex Trading's AGIO Position: Q1 2026 in Review

Simplex Trading increased its Agios Pharmaceuticals (AGIO) stake by 503% in Q1 2026, buying an estimated $886K and bringing the position to 37,462 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Simplex Trading first reported a position in AGIO in Q4 2014 and has held it in 28 quarters since. The position peaked at $2.08M in Q2 2018. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Simplex Trading held 37,462 shares of Agios Pharmaceuticals worth $1.27M as of Q1 2026.
  • Simplex Trading bought 31,253 Agios Pharmaceuticals shares in Q1 2026, an estimated $886K.
  • Agios Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2250 holding.
  • Simplex Trading first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 28 quarters since.
  • Simplex Trading's Agios Pharmaceuticals position peaked at $2.08M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.